Lanean...
Management of rheumatoid arthritis in People’s Republic of China – focus on tocilizumab and patient considerations
The prevalence of rheumatoid arthritis (RA) is 0.19%–0.41% in Chinese population. RA exerts profound influence on health-related quality of life (HRQoL), which imposed huge burdens on patients physically, mentally, and economically. As a developing country, People’s Republic of China faces enormous...
Gorde:
| Argitaratua izan da: | Int J Gen Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435442/ https://ncbi.nlm.nih.gov/pubmed/25999757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S81633 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|